Cell Lysis Market to Grow with a CAGR of 6.79% through 2028
Rising demand for biologics and personalized medicine is expected to
drive the Global Cell Lysis Market growth in the forecast period, 2024-2028.
According to
TechSci Research report, “Cell Lysis Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Cell
Lysis Market stood at USD 4.21 billion in 2022 and is anticipated to grow with
a CAGR of USD 3.04 billion 6.79% in the forecast period, 2024-2028. The
increasing prevalence of chronic diseases such as cancer, cardiovascular
disorders, and neurodegenerative conditions has stimulated the demand for cell
lysis in diagnostics. Cell lysis plays a pivotal role in the isolation of
disease biomarkers from patient samples. This allows for the development of
more accurate diagnostic tests and the monitoring of disease progression. As
healthcare providers and researchers seek better ways to diagnose and treat
chronic diseases, the cell lysis market is poised to benefit significantly. The
application of cell lysis techniques in clinical diagnostics has expanded
beyond traditional research settings. Cell lysis is now a critical component of
various diagnostic assays, including polymerase chain reaction (PCR),
enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing
(NGS). These techniques are used for detecting infectious diseases, genetic
disorders, and cancer biomarkers, among other clinical applications. The
growing demand for accurate and rapid diagnostic tests is a key driver for the
cell lysis market's growth.
The global cell lysis market owes much of its rapid growth to the
remarkable advancements within the biopharmaceutical industry. As
biopharmaceutical research continues to push the boundaries of therapeutic
development, cell lysis techniques will remain a cornerstone, enabling the
extraction of essential biomolecules, facilitating drug discovery, and
optimizing bioprocessing. Recent
advancements in genomics and proteomics research are focused on single-cell
analysis—a field that allows for the study of individual cells within a
heterogeneous population. Cell lysis plays a pivotal role in isolating and
analyzing the genetic and protein content of single cells, enabling researchers
to uncover cellular diversity, identify rare cell types, and gain insights into
cellular heterogeneity in health and disease. As the demands of genomics and
proteomics research evolve, so do the tools and reagents used in cell lysis.
Market players are continually developing innovative cell lysis solutions that
offer higher yields, improved selectivity, and increased automation. These
advancements cater to the specific needs of researchers working on cutting-edge
projects.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on
"Global Cell Lysis Market.”
Genomics researchers rely on cell lysis to extract high-quality DNA from
cells and tissues. This extracted DNA serves as the raw material for a wide
range of applications, including whole-genome sequencing, polymerase chain
reaction (PCR), and genetic testing. Efficient cell lysis techniques are
essential to obtain intact and uncontaminated DNA, ensuring the accuracy of
genetic analyses. To study how genes are turned on or off in response to
various conditions or diseases, researchers use techniques like RNA sequencing
(RNA-Seq) and microarrays. Cell lysis plays a critical role in isolating RNA,
allowing scientists to measure gene expression levels accurately. This
information is invaluable in understanding disease mechanisms and identifying
potential therapeutic targets. Genomics research involves studying genetic
variations, such as single nucleotide polymorphisms (SNPs) and copy number
variations (CNVs), to elucidate their roles in health and disease. Cell lysis
is instrumental in extracting DNA for genetic variation analysis, contributing
to the identification of genetic markers associated with diseases and drug
responses.
The Global Cell Lysis Market is segmented into Type of Product , Type of cells, End user, regional
distribution, and company.
Based on Type of Product, the Global Cell Lysis Market is segmented into Instruments and Reagents.
Based on the Type of Product, the Reagents segment emerged as the
dominant player in the global market for Cell Lysis in 2022.This is attributed
to several factors including essential role in cell lysis process, diverse
range of reagents, and customization and flexibility. Also, Leading suppliers
in the Reagents segment invest heavily in research and development to ensure
high-quality, standardized products. These reagents undergo rigorous testing
and quality control processes, providing researchers with confidence in their
reliability and consistency. The
Reagents segment encompasses a wide variety of products, including detergents,
enzymes, buffers, and specialized chemicals. This diversity allows researchers
and professionals to choose reagents tailored to their specific cell lysis
requirements. The availability of such options ensures that researchers can
select the most suitable reagents for their applications. The Reagents segment
offers flexibility and customization, allowing users to adapt cell lysis
protocols to various sample types and research goals. Researchers can select
reagents that are optimized for different cell types, ensuring efficient cell
disruption while maintaining sample integrity.
Based on type of cells, the Global Cell Lysis Market is segmented into Mammalian Cells, Microbial Cells, and Plant
Cells. Based on the Type of cells, the mammalian
cells segment emerged as the dominant player in the global market for Cell
Lysis in 2022. This is due to the widespread use of mammalian culture systems
in the bio-manufacturing of therapeutic proteins, viral vaccines, and other
recombinant products. Additionally, it is projected that adoption of 3D
mammalian culture techniques will promote sector growth in stem cell and cancer
research.
Mammalian cells are widely used
in the production of biopharmaceuticals, including monoclonal antibodies,
vaccines, and recombinant proteins. Cell lysis is a critical step in extracting
and purifying these therapeutic molecules, making it essential for the
biopharmaceutical industry's success. Mammalian
cell lines are invaluable tools in cancer research, enabling scientists to
study tumor biology, screen potential anticancer drugs, and investigate the
molecular mechanisms underlying cancer progression. Cell lysis is essential for
extracting proteins and nucleic acids from these cells to gain insights into
cancer-related pathways.
North America emerged as the dominant player in the global Cell Lysis
market in 2022, holding the largest market share. This is on account of several
key factors such as advanced healthcare infrastructure, Strong Research and
Development Ecosystem and high regulatory acceptance. North America,
particularly the United States, has a thriving biopharmaceutical industry. The
production of biologics, monoclonal antibodies, and gene therapies has been on
the rise, necessitating efficient cell lysis techniques for the extraction of
essential biomolecules. As the biopharmaceutical sector continues to grow, so
does the demand for cell lysis products and solutions.
Major companies operating in Global Cell Lysis Market are:
- Charles River
Laboratories Inc.
- The Jackson Laboratory
- Crown Bioscience,Inc.
- Altogen Labs
- Envigo
- WuxiAppTec
- Oncodesign
- Hera BioLabs
- XenTech
- Abnova Corporation
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The biopharmaceutical industry's rapid expansion, with a focus on
biologics, monoclonal antibodies, and gene therapies, is a major driver. Cell
lysis is integral to the production of these advanced therapies, necessitating efficient
and high-yield cell disruption methods. The continuous progress in genomics and
proteomics research is increasing the need for cell lysis techniques. Ongoing
technological advancements in cell lysis are streamlining processes and improving
efficiency. Automated systems, microfluidic devices, and robotics are enhancing
precision, reducing human error, and expanding the capabilities of cell lysis
techniques. Moreover, the growing applications of cell lysis in clinical
diagnostics, molecular pathology, and personalized medicine are driving demand.
Cell lysis is essential for accurate genetic testing, biomarker identification,
and targeted therapy development. These technologies are expected to drive the
growth of the market.” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Cell Lysis Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Type of Product (Instruments
{Homogeniser, Centrifugation, Other Types of Products}, Reagents), By Type of cells
(Mammalian Cells, Microbial Cells, Plant Cells), By End user (Biotechnology or
Biopharmaceutical Companies, Research Laboratories and Academic Institutes,
Other End Users) By Region and Competition”, has evaluated the future growth potential of Global Cell Lysis Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Cell Lysis Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com